These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15383331)

  • 1. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
    Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
    J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis.
    Lampugnani MG; Dejana E
    Thromb Res; 2007; 120 Suppl 2():S1-6. PubMed ID: 18023702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cadherins and tumor angiogenesis.
    Cavallaro U; Liebner S; Dejana E
    Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
    Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
    Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
    Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
    Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
    Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability.
    Dejana E; Lampugnani MG; Martinez-Estrada O; Bazzoni G
    Int J Dev Biol; 2000; 44(6):743-8. PubMed ID: 11061439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cadherins in the transendothelial migration of melanoma cells in culture.
    Sandig M; Voura EB; Kalnins VI; Siu CH
    Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrostatic pressure influences morphology and expression of VE-cadherin of vascular endothelial cells.
    Ohashi T; Sugaya Y; Sakamoto N; Sato M
    J Biomech; 2007; 40(11):2399-405. PubMed ID: 17261311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
    Kou R; SenBanerjee S; Jain MK; Michel T
    Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells.
    Martin TA; Mansel R; Jiang WG
    Clin Cancer Res; 2001 Mar; 7(3):734-7. PubMed ID: 11297270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
    Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
    Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
    Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
    Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond vessels: occurrence and regional clustering of vascular endothelial (VE-)cadherin-containing junctions in non-endothelial cells.
    Boda-Heggemann J; Régnier-Vigouroux A; Franke WW
    Cell Tissue Res; 2009 Jan; 335(1):49-65. PubMed ID: 19002500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.